XOMA Royalty Corp Share Price Today: Live Updates & Key Insights

XOMA Royalty Corp share price today is $26.9, up -0.37%. The stock opened at $26.457 against the previous close of $26.96, with an intraday high of $26.89 and low of $26.305.

XOMA Royalty Corp Share Price Chart

XOMA Royalty Corp

us-stock
To Invest in {{usstockname}}
us-stock

XOMA Royalty Corp Share Price Performance

$26.9 -0.0037(-0.37%) XOMA at 13 Mar 2026 03:57 PM Biotechnology
Lowest Today 26.305
Highest Today 26.89
Today’s Open 26.457
Prev. Close 26.96
52 Week High 39.92
52 Week Low 18.35
Day’s Range: Low 26.305 High 26.89
52-Week Range: Low 18.35 High 39.92
1 day return -
1 Week return +3.12
1 month return +11.36
3 month return +5.02
6 month return -29.4
1 year return +31.96
3 year return +28.17
5 year return -32.78
10 year return -

XOMA Royalty Corp Institutional Holdings

Bvf Inc 21.79

Morgan Stanley - Brokerage Accounts 13.85

FMR Inc 9.77

Fidelity Contrafund 6.11

Vanguard Group Inc 5.90

BlackRock Inc 4.99

Vanguard Total Stock Mkt Idx Inv 3.60

Opaleye Management Inc 2.46

Fidelity Contrafund Commingled Pl S 2.30

Woodline Partners LP 2.21

Morgan Stanley Insight 2.14

Morgan Stanley Insight I 2.14

iShares Russell 2000 ETF 1.88

Geode Capital Management, LLC 1.78

Morgan Stanley Inception 1.56

Morgan Stanley Inst Inception I 1.56

State Street Corp 1.41

Fidelity Contrafund K6 1.30

MS INVF Global Insight Z 1.17

EQ/Morgan Stanley Small Cap Growth K 0.98

Stonepine Capital Management Llc 0.97

HighVista Strategies LLC 0.95

Vanguard Institutional Extnd Mkt Idx Tr 0.88

Northern Trust Corp 0.80

Fidelity Small Cap Index 0.78

Bank of New York Mellon Corp 0.52

Mercer Global Small Cap Equity M-5£ 0.48

iShares Russell 2000 Growth ETF 0.48

Fidelity Extended Market Index 0.42

TLS Advisors LLC 0.40

Vanguard Russell 2000 ETF 0.38

Dimensional Fund Advisors, Inc. 0.36

CM Management, LLC 0.34

Nordea 1 - Global Small Cap BI USD 0.33

State St Russell Sm/Mid Cp® Indx SL Cl I 0.33

Renaissance Technologies Corp 0.33

State St Russell Sm Cap® Indx SL Cl I 0.27

RBF LLC 0.25

Wellington Management Company LLP 0.25

Charles Schwab Investment Management Inc 0.25

XOMA Royalty Corp Market Status

Strong Buy: 2

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

XOMA Royalty Corp Fundamentals

Market Cap 333.85 M

PB Ratio 2.9702

PE Ratio 35.9467

Enterprise Value 405.77 M

Total Assets 221.28 M

Volume 95109

XOMA Royalty Corp Company Financials

Annual Revenue FY23:4411000 4.4M, FY22:6027000 6.0M, FY21:38160000 38.2M, FY20:29385000 29.4M, FY19:18370000 18.4M

Annual Profit FY23:null 0.0M, FY22:5930000 5.9M, FY21:38160000 38.2M, FY20:29385000 29.4M, FY19:18370000 18.4M

Annual Net worth FY23:-26698000 -26.7M, FY22:-17104000 -17.1M, FY21:15798000 15.8M, FY20:13298000 13.3M, FY19:-7698000 -7.7M

Quarterly Revenue Q3/2025:9351000 9.4M, Q2/2025:13129000 13.1M, Q1/2025:15912000 15.9M, Q3/2024:7197000 7.2M, Q2/2024:11086000 11.1M

Quarterly Profit Q3/2025:8473000 8.5M, Q2/2025:12471000 12.5M, Q1/2025:15368000 15.4M, Q3/2024:7197000 7.2M, Q2/2024:11083000 11.1M

Quarterly Net worth Q3/2025:14051000 14.1M, Q2/2025:6890000 6.9M, Q1/2025:2367000 2.4M, Q3/2024:-17243000 -17.2M, Q2/2024:15985000 16.0M

About XOMA Royalty Corp & investment objective

Company Information XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Mr. Owen P. Hughes Jr.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right